Cell Therapeutics Inc. (NASDAQ:CTIC) on Feb. 3 announced that Karen Ignagni has been appointed a director of CTIC, effective immediately. Ignagni currently serves as President and CEO of America’s Health Insurance Plans, or AHIP, which is the trade association representing U.S. health plan. Cell Therapeutics Inc. (NASDAQ:CTIC) stock opened at $3.20in last session, and closed at $3.42, while the day range of Cell Therapeutics Inc. (NASDAQ:CTIC) stock is $3.16 – $3.49. The stock showed a positive weekly performance of 2.09%.
The Rosen Law Firm on Feb. 18 announced that it is investigating potential securities fraud claims against Galena Biopharma, Inc. (NAASDAQ:GALE) resulting from allegations that GALE may have paid outsiders to pump its stock using false and misleading articles while insiders dumped their shares. Galena Biopharma Inc. (NASDAQ:GALE) stock opened at $3.67, in last session and closed at $3.91by gaining8.61%.The 52 week range of $1.65 – $7.77. Company’s market capitalization is $341.42M.
Shares of HomeAway Inc. (NASDAQ:AWAY) were looking appealing, climbing as much as 13% after a promising outlook in its fourth-quarter report. HomeAway, Inc. (NASDAQ:AWAY) stock increased 12.57% and finished the last session at $48.36. The EPS of the stock remained0.27.Company’s market capitalization is $4.13B.
Microvision, Inc. (NASDAQ:MVIS) is involved in the development high-resolution small laser show and picture google based upon its exclusive PicoP show engine technology. Microvision, Inc.(NASDAQ:MVIS) stock opened the session at $1.51, and closed the session at $2.67. The 52 week range of theMicrovision, Inc.(NASDAQ:MVIS)stock remained $1.03 – $3.49and the day range was $1.48 – $3.18.